loperamide has been researched along with fluorodeoxyglucose f18 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Masdeu, JC; Pascual, B; Rostomily, RC; Turkheimer, F; Veronese, M; Zanotti-Fregonara, P | 1 |
Ishimori, T; Kimura, H; Koyasu, S; Nakamoto, Y; Nobashi, T; Saga, T; Shimizu, Y; Togashi, K; Watanabe, M | 1 |
2 other study(ies) available for loperamide and fluorodeoxyglucose f18
Article | Year |
---|---|
The validity of
Topics: Animals; Biomarkers; Biopsy; Blood-Brain Barrier; Brain; Brain Neoplasms; Carbazoles; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genotype; Humans; Indoles; Inflammation; Ligands; Loperamide; Multiple Sclerosis; Positron-Emission Tomography; Protein Binding; Purines; Receptors, GABA; Reproducibility of Results; Verapamil | 2019 |
Enhanced intestinal 2-deoxy-2-[18F]fluoro-D-glucose uptake under metformin is not fully suppressed by loperamide.
Topics: Animals; Biological Transport; Drug Interactions; Fluorodeoxyglucose F18; Intestinal Absorption; Intestinal Mucosa; Intestines; Loperamide; Male; Metformin; Mice; Mice, Inbred C57BL; Positron Emission Tomography Computed Tomography | 2018 |